Henan Lingrui Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600285.SS

Henan Lingrui Pharmaceutical Co., Ltd. Dividend Yield on January 14, 2025: 2.96%

Henan Lingrui Pharmaceutical Co., Ltd. Dividend Yield is 2.96% on January 14, 2025, a -16.67% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Henan Lingrui Pharmaceutical Co., Ltd. 52-week high Dividend Yield is 3.80% on January 22, 2024, which is 28.56% above the current Dividend Yield.
Henan Lingrui Pharmaceutical Co., Ltd. 52-week low Dividend Yield is 2.29% on October 08, 2024, which is -22.44% below the current Dividend Yield.
Henan Lingrui Pharmaceutical Co., Ltd. average Dividend Yield for the last 52 weeks is 2.81%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

Shanghai Stock Exchange: 600285.SS

Henan Lingrui Pharmaceutical Co., Ltd.

CEO	Mr. Wei Xiong
IPO Date	Oct. 18, 2000
Location	China
Headquarters	No.666 Jiangjun Road
Employees	2,530
Sector	Health Care
Industries Pharmaceuticals Cosmetics

Description

Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering approximately 100 product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is based in Xinyang, China.

Key trends

Past 5 years